C Pharma (formerly known as Green Cross) has announced that it has received approval from the South Korean Ministry of Food and Drug Safety (MFDS) expanding the indication for GCFLU Quadrivalent (Seasonal Influenza Vaccine) to include use in persons 6 months and older. Prior to this, the vaccine was approved for use in persons 3 years of age and older.
« The flu is a serious diseases with a significant impact on public health, « said Byung-Wha Kim GC Pharma Executive Vice President. « The expanded indication builds upon GC Pharma’s legacy as the first local manufacturer to bring quadrivalent flu vaccines to the South Korean marketplace. »…
